Zürcher Nachrichten - Who should get paid for nature's sequenced genes?

EUR -
AED 4.26336
AFN 72.539743
ALL 95.969597
AMD 436.761633
ANG 2.078085
AOA 1064.533294
ARS 1622.239954
AUD 1.665755
AWG 2.092209
AZN 1.969529
BAM 1.955155
BBD 2.333461
BDT 142.163126
BGN 1.984315
BHD 0.438291
BIF 3440.935805
BMD 1.160887
BND 1.482398
BOB 8.023389
BRL 6.057509
BSD 1.158533
BTN 108.556609
BWP 15.874697
BYN 3.429869
BYR 22753.389691
BZD 2.330162
CAD 1.601177
CDF 2643.919879
CHF 0.915354
CLF 0.026906
CLP 1062.339221
CNY 8.001646
CNH 8.006409
COP 4301.342579
CRC 539.805739
CUC 1.160887
CUP 30.763512
CVE 110.230079
CZK 24.422339
DJF 206.314639
DKK 7.471476
DOP 69.405023
DZD 153.81363
EGP 61.066959
ERN 17.413308
ETB 179.100647
FJD 2.600677
FKP 0.867445
GBP 0.864925
GEL 3.140219
GGP 0.867445
GHS 12.657881
GIP 0.867445
GMD 85.321598
GNF 10154.564337
GTQ 8.872189
GYD 242.46692
HKD 9.074133
HNL 30.67796
HRK 7.537175
HTG 151.908604
HUF 389.104442
IDR 19589.971991
ILS 3.616338
IMP 0.867445
INR 109.019845
IQD 1517.69958
IRR 1524273.954377
ISK 143.799761
JEP 0.867445
JMD 182.824207
JOD 0.823051
JPY 184.365141
KES 150.462767
KGS 101.518661
KHR 4649.426928
KMF 494.537784
KPW 1044.815161
KRW 1737.721097
KWD 0.355777
KYD 0.965482
KZT 559.295588
LAK 24943.775471
LBP 103754.689722
LKR 364.169925
LRD 212.602647
LSL 19.751088
LTL 3.427798
LVL 0.702209
LYD 7.38666
MAD 10.800599
MDL 20.263319
MGA 4837.30086
MKD 61.648395
MMK 2438.057732
MNT 4143.749921
MOP 9.336622
MRU 46.206372
MUR 53.934929
MVR 17.946995
MWK 2008.89436
MXN 20.584621
MYR 4.602915
MZN 74.19248
NAD 19.751088
NGN 1599.354434
NIO 42.635575
NOK 11.294841
NPR 173.683496
NZD 1.992756
OMR 0.446361
PAB 1.158523
PEN 4.007379
PGK 5.003307
PHP 69.633526
PKR 323.679158
PLN 4.267218
PYG 7559.605105
QAR 4.224862
RON 5.094906
RSD 117.448079
RUB 93.885915
RWF 1694.890056
SAR 4.354847
SBD 9.335826
SCR 15.98465
SDG 697.693459
SEK 10.763046
SGD 1.483788
SHP 0.870966
SLE 28.553338
SLL 24343.237318
SOS 662.061742
SRD 43.347429
STD 24028.021821
STN 24.491714
SVC 10.137657
SYP 128.798415
SZL 19.749403
THB 37.717178
TJS 11.116578
TMT 4.074714
TND 3.398223
TOP 2.795137
TRY 51.494061
TTD 7.871405
TWD 37.026486
TZS 2983.548704
UAH 50.880828
UGX 4338.513435
USD 1.160887
UYU 47.215042
UZS 14134.339587
VES 532.705795
VND 30589.378487
VUV 138.735394
WST 3.178743
XAF 655.726671
XAG 0.015845
XAU 0.000253
XCD 3.137356
XCG 2.088012
XDR 0.815514
XOF 655.749258
XPF 119.331742
YER 276.985155
ZAR 19.558738
ZMK 10449.374887
ZMW 21.926054
ZWL 373.805214
  • CMSC

    0.0800

    22.95

    +0.35%

  • NGG

    1.7500

    84.08

    +2.08%

  • RIO

    1.2600

    88.03

    +1.43%

  • BCE

    -0.0720

    25.758

    -0.28%

  • BCC

    0.5650

    74.135

    +0.76%

  • BP

    0.4950

    45.285

    +1.09%

  • RBGPF

    -13.5000

    69

    -19.57%

  • GSK

    1.5050

    54.455

    +2.76%

  • BTI

    0.6400

    58.4

    +1.1%

  • CMSD

    0.1650

    22.795

    +0.72%

  • JRI

    0.3900

    12.25

    +3.18%

  • RYCEF

    0.4000

    16

    +2.5%

  • VOD

    0.1100

    14.77

    +0.74%

  • AZN

    2.1000

    187.88

    +1.12%

  • RELX

    -0.0700

    32.39

    -0.22%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: Menahem KAHANA - AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

N.Zaugg--NZN